 |
United Therapeutics UTHR (news,
chart,
quote) - UTHR volatility Flat into Phase three results
UTHR closed at $89.02. Cowen say's "Phase three data from the TRIUMPH trial of UTHR's Viveta to be released on May 21, and Phase three data from UTHR's oral Remod |
|
